Works by Kitade, Mitsuteru


Results: 43
    1
    2
    3
    4

    Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.

    Published in:
    Molecular Medicine Reports, 2015, v. 11, n. 3, p. 1693, doi. 10.3892/mmr.2014.2995
    By:
    • DOUHARA, AKITOSHI;
    • MORIYA, KEI;
    • YOSHIJI, HITOSHI;
    • NOGUCHI, RYUICHI;
    • NAMISAKI, TADASHI;
    • KITADE, MITSUTERU;
    • KAJI, KOSUKE;
    • AIHARA, YOSUKE;
    • NISHIMURA, NORIHISA;
    • TAKEDA, KOSUKE;
    • OKURA, YASUSHI;
    • KAWARATANI, HIDETO;
    • FUKUI, HIROSHI
    Publication type:
    Article
    5

    Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection.

    Published in:
    Experimental & Therapeutic Medicine, 2018, v. 16, n. 3, p. 2743, doi. 10.3892/etm.2018.6481
    By:
    • Takeda, Kosuke;
    • Noguchi, Ryuichi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Seki, Kenichiro;
    • Fujinaga, Yukihisa;
    • Tsuji, Yuki;
    • Kubo, Takuya;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Kitagawa, Koh
    Publication type:
    Article
    6

    Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection.

    Published in:
    Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 65, doi. 10.3350/cmh.2018.0070
    By:
    • Shinya Sato;
    • Kei Moriya;
    • Masanori Furukawa;
    • Soichiro Saikawa;
    • Tadashi Namisaki;
    • Mitsuteru Kitade;
    • Hideto Kawaratani;
    • Kosuke Kaji;
    • Hiroaki Takaya;
    • Naotaka Shimozato;
    • Yasuhiko Sawada;
    • Kenichiro Seki;
    • Koh Kitagawa;
    • Takemi Akahane;
    • Akira Mitoro;
    • Yasushi Okura;
    • Junichi Yamao;
    • Hitoshi Yoshiji
    Publication type:
    Article
    7

    Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection.

    Published in:
    Clinical & Molecular Hepatology, 2019, v. 25, n. 1, p. 65, doi. 10.3350/cmh.2018.0070
    By:
    • Shinya Sato;
    • Kei Moriya;
    • Masanori Furukawa;
    • Soichiro Saikawa;
    • Tadashi Namisaki;
    • Mitsuteru Kitade;
    • Hideto Kawaratani;
    • Kosuke Kaji;
    • Hiroaki Takaya;
    • Naotaka Shimozato;
    • Yasuhiko Sawada;
    • Kenichiro Seki;
    • Koh Kitagawa;
    • Takemi Akahane;
    • Akira Mitoro;
    • Yasushi Okura;
    • Junichi Yamao;
    • Hitoshi Yoshiji
    Publication type:
    Article
    8
    9

    Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.

    Published in:
    International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 2164, doi. 10.3390/ijms21062164
    By:
    • Ozutsumi, Takahiro;
    • Namisaki, Tadashi;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Tsuji, Yuki;
    • Kaya, Daisuke;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Nakanishi, Keisuke;
    • Sato, Shinya;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Kitagawa, Koh;
    • Takaya, Hiroaki;
    • Kawaratani, Hideto;
    • Kitade, Mitsuteru;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Akahane, Takemi;
    • Mitoro, Akira
    Publication type:
    Article
    10

    Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.

    Published in:
    International Journal of Molecular Sciences, 2019, v. 20, n. 11, p. 2724, doi. 10.3390/ijms20112724
    By:
    • Nakanishi, Keisuke;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Kubo, Takuya;
    • Furukawa, Masanori;
    • Saikawa, Soichiro;
    • Shimozato, Naotaka;
    • Sato, Shinya;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats

    Published in:
    Hepatology Research, 2006, v. 35, n. 3, p. 199, doi. 10.1016/j.hepres.2006.03.010
    By:
    • Namisaki, Tadashi;
    • Yoshiji, Hitoshi;
    • Kuriyama, Shigeki;
    • Kojima, Hideyuki;
    • Yoshii, Junichi;
    • Ikenaka, Yasuhide;
    • Noguchi, Ryuichi;
    • Sakurai, Shinya;
    • Yanase, Koji;
    • Kitade, Mitsuteru;
    • Yamazaki, Masaharu;
    • Asada, Kiyoshi;
    • Tsujimoto, Tatsuhiro;
    • Akahane, Takemi;
    • Uemura, Masahito;
    • Fukui, Hiroshi
    Publication type:
    Article
    18
    19
    20
    21
    22

    Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.

    Published in:
    Hepatology Research, 2020, v. 50, n. 7, p. 840, doi. 10.1111/hepr.13509
    By:
    • Furukawa, Masanori;
    • Moriya, Kei;
    • Nakayama, Jiro;
    • Inoue, Takako;
    • Momoda, Rie;
    • Kawaratani, Hideto;
    • Namisaki, Tadashi;
    • Sato, Shinya;
    • Douhara, Akitoshi;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Shimozato, Naotaka;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Takaya, Hiroaki;
    • Kitagawa, Koh;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    23

    Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1147, doi. 10.1111/hepr.13385
    By:
    • Shimozato, Naotaka;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Kitagawa, Koh;
    • Tsuji, Yuki;
    • Kaya, Daisuke
    Publication type:
    Article
    24

    Identification of clinical risk factors for histological progression of primary biliary cholangitis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 9, p. 1015, doi. 10.1111/hepr.13355
    By:
    • Fujinaga, Yukihisa;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Seki, Kenichiro;
    • Akahane, Takemi;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Kubo, Takuya;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Tsuji, Yuki
    Publication type:
    Article
    25
    26

    Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 3, p. 284, doi. 10.1111/hepr.13281
    By:
    • Sawada, Yasuhiko;
    • Kawaratani, Hideto;
    • Kubo, Takuya;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Saikawa, Soichiro;
    • Sato, Shinya;
    • Seki, Kenichiro;
    • Takaya, Hiroaki;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Shimozato, Naotaka;
    • Mashitani, Tsuyoshi;
    • Kitade, Mitsuteru;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    27

    Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 2, p. 232, doi. 10.1111/hepr.13249
    By:
    • Okura, Yasushi;
    • Namisaki, Tadashi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Seki, Kenichiro;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Kaya, Daisuke;
    • Tsuji, Yuki;
    • Ozutsumi, Takahiro
    Publication type:
    Article
    28
    29

    Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

    Published in:
    Hepatology Research, 2017, v. 47, n. 12, p. 1317, doi. 10.1111/hepr.12860
    By:
    • Okura, Yasushi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kitade, Mitsuteru;
    • Takeda, Kosuke;
    • Kaji, Kosuke;
    • Noguchi, Ryuichi;
    • Nishimura, Norihisa;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sato, Shinya;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Furukawa, Masanori;
    • Nakanishi, Keisuke;
    • Saikawa, Soichiro;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    30

    Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.

    Published in:
    Hepatology Research, 2017, v. 47, n. 9, p. 854, doi. 10.1111/hepr.12826
    By:
    • Kawaratani, Hideto;
    • Fukui, Hiroshi;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Namisaki, Tadashi;
    • Uejima, Masakazu;
    • Kitade, Mitsuteru;
    • Takeda, Kosuke;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Nishimura, Norihisa;
    • Takaya, Hiroaki;
    • Aihara, Yousuke;
    • Sawada, Yasuhiko;
    • Sato, Shinya;
    • Seki, Kenichiro;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    31

    Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis.

    Published in:
    Hepatology Research, 2017, v. 47, n. 3, p. E178, doi. 10.1111/hepr.12746
    By:
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Yamao, Junichi;
    • Mitoro, Akira;
    • Yoshida, Motoyuki;
    • Sawai, Masayoshi;
    • Uejima, Masakazu;
    • Mashitani, Tsuyoshi;
    • Takeda, Kosuke;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Aihara, Yosuke;
    • Douhara, Akitoshi;
    • Nishimura, Norihisa;
    • Sawada, Yasuhiko;
    • Sato, Shinya
    Publication type:
    Article
    32
    33
    34
    35

    Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.

    Published in:
    Oncology Letters, 2017, v. 14, n. 3, p. 3028, doi. 10.3892/ol.2017.6489
    By:
    • Akitoshi Douhara;
    • Tadashi Namisaki;
    • Kei Moriya;
    • Mitsuteru Kitade;
    • Kosuke Kaji;
    • Hideto Kawaratani;
    • Kosuke Takeda;
    • Yasushi Okura;
    • Hiroaki Takaya;
    • Ryuichi Noguchi;
    • Norihisa Nishimura;
    • Kenichiro Seki;
    • Shinya Sato;
    • Yasuhiko Sawada;
    • Junichi Yamao;
    • Akira Mitoro;
    • Masakazu Uejima;
    • Tsuyoshi Mashitani;
    • Naotaka Shimozato;
    • Soichiro Saikawa
    Publication type:
    Article
    36

    Calcified mucinous adenocarcinoma of the stomach metastatic to the iris: a case report.

    Published in:
    2019
    By:
    • Kaneko, Miki;
    • Namisaki, Tadashi;
    • Takaya, Hiroaki;
    • Mori, Hitoshi;
    • Kitade, Mitsuteru;
    • Okura, Yasushi;
    • Seki, Kenichiro;
    • Sato, Shinya;
    • Nakanishi, Keisuke;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Otani, Tomoyuki;
    • Nakai, Tokiko;
    • Obayashi, Chiho;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Yoshiji, Hitoshi
    Publication type:
    journal article
    37

    Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.

    Published in:
    In Vivo, 2022, v. 36, n. 3, p. 1477, doi. 10.21873/invivo.12854
    By:
    • TADASHI NAMISAKI;
    • YUKI TSUJI;
    • MITSUTERU KITADE;
    • NOBUYUKI YORIOKA;
    • YUKIHISA FUJINAGA;
    • YASUHIKO SAWADA;
    • NORIHISA NISHIMURA;
    • KOH KITAGAWA;
    • TAKASHI INOUE;
    • HIROAKI TAKAYA;
    • KOSUKE KAJI;
    • HIDETO KAWARATANI;
    • KEI MORIYA;
    • TAKEMI AKAHANE;
    • AKIRA MITORO;
    • HITOSHI YOSHIJI
    Publication type:
    Article
    38

    Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis.

    Published in:
    International Journal of Molecular Medicine, 2017, v. 40, n. 2, p. 263, doi. 10.3892/ijmm.2017.3015
    By:
    • HIDETO KAWARATANI;
    • KEI MORIYA;
    • TADASHI NAMISAKI;
    • MASAKAZU UEJIMA;
    • MITSUTERU KITADE;
    • KOUSUKE TAKEDA;
    • YASUSHI OKURA;
    • KOUSUKE KAJI;
    • HIROAKI TAKAYA;
    • NORIHISA NISHIMURA;
    • SHINYA SATO;
    • YASUHIKO SAWADA;
    • KENICHIRO SEKI;
    • TAKUYA KUBO;
    • AKIRA MITORO;
    • JUNICHI YAMAO;
    • HITOSHI YOSHIJI
    Publication type:
    Article
    39
    40

    Gastric adenocarcinoma of fundic gland type (chief cell predominant type) with unique endoscopic appearance curatively treated by endoscopic submucosal resection.

    Published in:
    Acta Gastro-Enterologica Belgica, 2015, v. 78, n. 3, p. 336
    By:
    • Soichi Takeda;
    • Akira Mitoro;
    • Tadashi Namisaki;
    • Motoyuki Yoshida;
    • Masayoshi Sawai;
    • Junichi Yamao;
    • Hitoshi Yoshiji;
    • Masakazu Uejima;
    • Kei Moriya;
    • Akitoshi Douhara;
    • Kenichiro Seki;
    • Koji Ishida;
    • Kouhei Morita;
    • Ryuichi Noguchi;
    • Mitsuteru Kitade;
    • Hideto Kawaratani;
    • Yasushi Okura;
    • Hiroaki Takaya;
    • Hiroshi Fukui
    Publication type:
    Article
    41
    42
    43